Thomas Stankovich - Chief Financial Officer at ReShape Lifesciences Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
RSLS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

Thomas Stankovich - trading volume in the past year for ReShape Lifesciences Inc.

Holdings reported by Thomas Stankovich for ReShape Lifesciences Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.001 par value per share 22.9K $6.2K $0.27 Oct 25, 2023 Direct
Common Stock, $0.001 par value per share 22.8K $5.69K $0.25 May 31, 2024 Direct

Transactions reported by Thomas Stankovich for ReShape Lifesciences Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.